Motilal Oswal has reiterated a “buy” rating on Glenmark Pharmaceuticals with a raised target price of Rs 2,430, implying a...
Read moreTata Elxsi shares will be in focus on Friday after the company reported a 22% year-on-year decline in consolidated net...
Read moreShares of Kirloskar Ferrous Industries have rebounded 29% in the last three months thereby reducing the one-year fall to 22%....
Read moreHaryana-based Aggcon Equipments International, a fast-growing infrastructure equipment rental company, has filed its Draft Red Herring Prospectus (DRHP) with the...
Read moreAfter staging a sharp 24% rally in 2025 and nearing record highs, shares of Reliance Industries Ltd (RIL) have begun...
Read moreShares of Oil India and GAIL India will be in focus on Thursday after both companies signed an agreement to...
Read moreZerodha founder and CEO Nithin Kamath on Wednesday noted that design tricks used in financial apps and websites are made...
Read moreMarkets watchdog Sebi on Wednesday proposed permitting credit rating agencies (CRAs) to undertake the rating of financial instruments that may...
Read moreWhile banks have delivered solid gains in 2025, it’s the Non-Banking Financial Companies (NBFCs) that are quietly and powerfully stealing...
Read moreSwiggy shares have staged a sharp rebound ahead of the Q1FY26 earnings season, rallying 27.9% from their all-time low of...
Read more© 2024 LSD News title="Jegtheme">Jegtheme.